Evidence map›Paper›PMID 36271410›Full record

Trial reportCritical care (London, England)2022

Oxygen targets and 6-month outcome after out of hospital cardiac arrest: a pre-planned sub-analysis of the targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial.

Chiara Robba, Rafael Badenes, Denise Battaglini, Lorenzo Ball, Filippo Sanfilippo, Iole Brunetti, Janus Christian Jakobsen, Gisela Lilja, Hans Friberg, Pedro David Wendel-Garcia and 20 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Critical care (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02908308 (Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest), which is not on this map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02908308 nacompletednot on this map

Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest (TTM2) - A Randomised Clinical Trial

TypeinterventionalSponsorHelsingborgs HospitalRan2017 to 2022Enrolled1,900ConditionsOut-of-hospital Cardiac ArrestArmsTargeted temperature management to 33°C, Standard care with early treatment of fever
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 12 countries.

Chiara Robba *Anesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy. kiarobba@gmail.com.ORCID 0000-0003-1628-3845
Rafael Badenes *Department of Anesthesiology and Surgical-Trauma Intensive Care, Hospital Clínic Universitari de Valencia, Valencia, Spain.
Denise BattagliniAnesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy.
Lorenzo BallAnesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy.
Filippo SanfilippoDepartment of Anaesthesia and Intensive Care, A.O.U. "Policlinico-San Marco", Catania, Italy.
Iole BrunettiAnesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy.
Janus Christian JakobsenCopenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Gisela LiljaDepartment of Clinical Sciences Lund, Neurology, Skåne University Hospital, Lund University, Getingevägen 4, 222 41, Lund, Malmö, Sweden.
Hans FribergDepartment of Clinical Sciences Lund, Anesthesia and Intensive Care, Lund University, Lund, Sweden.
Pedro David Wendel-GarciaInstitute of Intensive Care Medicine, University Hospital of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Paul J YoungMedical Research Institute of New Zealand, Private Bag 7902, Wellington, 6242, New Zealand.
Glenn EastwoodAustralian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Michelle S ChewDepartment of Anaesthesia and Intensive Care, Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Johan UndenDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Matthew ThomasUniversity Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Michael JoannidisDivision of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
Alistair NicholMonash University, Melbourne, VIC, Australia.
Andreas LundinDepartment of Anaesthesiology and Intensive Care Medicine, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 423 45, Gothenburg, Sweden.
Jacob HollenbergDepartment of Clinical Science and Education, Södersjukhuset, Centre for Resuscitation Science, Karolinska Institutet, Solna, Sweden.
Naomi HammondMalcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Critical Care Division, The George Institute for Global Health, Faculty of Medicine, UNSW Sydney, Sydney, Australia.
Manoj SaxenaIntensive Care Unit, St George Hospital, Sydney, Australia.
Annborn MartinDepartment of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, Lund, Sweden.
Miroslav SolarDepartment of Internal Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
Fabio Silvio TacconeDepartment of Intensive Care Medicine, Université Libre de Bruxelles, Hopital Erasme, Brussels, Belgium.
Josef DankiewiczDepartment of Clinical Sciences Lund, Cardiology, Skåne University Hospital, Lund University, Lund, Sweden.
Niklas NielsenDepartment of Clinical Sciences Lund, Anaesthesia and Intensive Care and Clinical Sciences Helsingborg, Helsingborg Hospital, Lund University, Lund, Sweden.
Anders Morten GrejsDepartment of Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
Florian Ebner *Department of Clinical Sciences Lund, Anesthesia and Intensive Care, Helsingborg Hospital, Lund University, 251 87, Helsingborg, Sweden.
Paolo Pelosi *Anesthesia and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy.
TTM2 Trial collaborators
Lund University · SEUniversity Hospital of Zurich · CHUniversity of Southern Denmark · DKThe University of Melbourne · AUOspedale Policlinico San Martino · ITUniversity Hospitals Bristol NHS Foundation Trust · GBCharles University · CZUniversity of Gothenburg · SEAarhus University Hospital · DKInnsbruck Medical University · ATAarhus University · DKLinköping University · SEMonash University · AUPoliclinico Universitario di Catania · ITUniversité Libre de Bruxelles · BEAustin Hospital · AUKarolinska Institutet · SERoyal North Shore Hospital · AUSt George Hospital · AUUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOptimal oxygen targets in patients resuscitated after cardiac arrest are uncertain. The primary aim of this study was to describe the values of partial pressure of oxygen values (PaO

methodsPreplanned secondary analysis of the targeted hypothermia versus targeted normothermia after OHCA (TTM2) trial. Arterial blood gases values were collected from randomization every 4 h for the first 32 h, and then, every 8 h until day 3. Hypoxemia was defined as PaO

results1418 patients were included in the analysis. The mean age was 64 ± 14 years, and 292 patients (20.6%) were female. 24.9% of patients had at least one episode of hypoxemia, and 7.6% of patients had at least one episode of severe hyperoxemia. Both hypoxemia and hyperoxemia were independently associated with 6-month mortality, but not with poor neurological outcome. The best cutoff point associated with 6-month mortality for hypoxemia was 69 mmHg (Risk Ratio, RR = 1.009, 95% CI 0.93-1.09), and for hyperoxemia was 195 mmHg (RR = 1.006, 95% CI 0.95-1.06). The time exposure, i.e., the area under the curve (PaO

conclusionsIn OHCA patients, both hypoxemia and hyperoxemia are associated with 6-months mortality, with an effect mediated by the timing exposure to high values of oxygen. Precise titration of oxygen levels should be considered in this group of patients.

trial registrationclinicaltrials.gov NCT02908308 , Registered September 20, 2016.

Indexed as

HypothermiaOut-of-Hospital Cardiac ArrestAgedFemaleHumansHypoxiaMaleMiddle AgedOxygenPartial PressureOxygenCardiac arrestHyperoxemiaHypoxemiaMortalityNeurological outcome

Identifiers

PMID36271410
PMCPMC9585831
OpenAlexW4306977220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.